Quest Diagnostics (DGX) Tops Q2 EPS by 210c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Quest Diagnostics (DGX) PT Raised to $160 at Jefferies
July 23, 2021 8:44 AM EDTJefferies analyst Brian Tanquilut raised the price target on Quest Diagnostics (NYSE: DGX) to $160.00 (from $155.00) while maintaining a Buy rating.
The analyst commented, "e are positive on DGX given our view that continued improvement in core fundamentals -- driven by accelerating payor-driven... More
